Clinical Trial

Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)

Recruiting
View on ClinicalTrials.gov →
Summary
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-10; most recent amendment 2024-05-24.
Status change: Not Yet Recruiting → Recruiting 2024-05-24
Trial Details
NCT Number NCT06133244
Lead Sponsor UMC Utrecht
Collaborators: University Medical Center Groningen, Radboud University Medical Center, Leiden University Medical Center, Royal Free Hospital NHS Foundation Trust
Conditions Systemic Sclerosis
Enrollment 300 participants
Start Date 2024-04-19
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2024-05-28